February 25, 2013 Astex Pharmaceuticals Reports 2012 Fourth Quarter and Year-End Financial Results Reports Annual Net Income of $8.2 Million Dacogen Royalty Revenue Increases 17.5% from Prior Year Ends Year with $138 Mi

Source URL: astx.com

• Taxation
• Intellectual property law
• Generally Accepted Accounting Principles
• Financial statements
• Financial accounting
• Income tax in the United States
• Deferral
• Balance sheet
• Amortization
• Accountancy
• Finance
• Business

October 30, 2012 Astex Pharmaceuticals Reports 2012 Third Quarter Financial Results Dacogen Approved in the European Union for the Treatment of Elderly AML Initiated HSP90 Inhibitor AT13387 Clinical Trials in Prostate &

Source URL: astx.com

• Generally Accepted Accounting Principles
• Taxation
• Financial statements
• Financial accounting
• Financial markets
• Balance sheet
• Income tax in the United States
• Deferral
• Income tax
• Finance
• Accountancy
• Business

September 21, 2012 Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedica

Source URL: astx.com

• Organic chemistry
• Alkynes
• Astex
• Small-cell carcinoma
• Clinical trial
• Homologous recombination
• Erlotinib
• Medicine
• Chemistry
• Lung cancer

January 2, 2013 Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients DUBLIN, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasda

Source URL: astx.com

• Hepatology
• Hepatocellular carcinoma
• Sorafenib
• Myelodysplastic syndrome
• Acute myeloid leukemia
• Medicine
• Oncology
• Chemistry

January 16, 2013 Cancer Research UK and Cancer Research Technology Initiate AT13148 Clinical Trial to Treat Several Cancer Types DUBLIN, Calif., Jan. 16, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX

Source URL: astx.com

• Cancer organizations
• Cancer research
• Association of Commonwealth Universities
• Institute of Cancer Research
• University of London
• Astex
• Cancer Research UK
• Abiraterone
• Medical research
• Medicine
• Health
• Oncology

October 24, 2012 Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer DUBLIN, Calif., Oct. 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceu

Source URL: astx.com

• Organofluorides
• Piperidines
• Lung cancer
• Crizotinib
• Pyrazoles
• Anaplastic lymphoma kinase
• Non-small-cell lung carcinoma
• Hsp90
• Erlotinib
• Chemistry
• Organic chemistry
• Pfizer

June 13, 2012 Astex Pharmaceuticals Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor DUBLIN, Calif., June 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a phar

Source URL: astx.com

• Protein kinase inhibitor
• Drug discovery
• Pharmaceutical sciences
• Pharmacology
• Astex

Astex Pharmaceuticals to Host Annual Analyst and Investor Day on March 27, 2012 DUBLIN, Calif.--(BUSINESS WIRE)-- Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and develop

Source URL: astx.com

Astex Pharmaceuticals to Present AT26893, a Novel Targeted Approach to the Treatment of HCV at EASL DUBLIN, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX - News), a pharmaceutical co

Source URL: astx.com

• Antiviral drug
• Allosteric regulation
• Astex
• Hepatitis C virus
• Proteins

July 10, 2012 Astex Board Member Wins 2012 European Mediscience Award DUBLIN, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and

Source URL: astx.com

• Astex
• Evotec
• Vernalis plc